Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, Chatenoud L, Eshagh D, Szwebel TA, Martinot M, Camou F, Crickx E, Michel M, Mahevas M, Boutboul D, Azoulay E, Joseph A, Hermine O, Rouzaud C, Faguer S, Petua P, Pommeret F, Clerc S, Planquette B, Merabet F, London J, Zeller V, Ghez D, Veyer D, Ouedrani A, Gallian P, Pacanowski J, Mékinian A, Garnier M, Pirenne F, Tiberghien P, Lacombe K. Hueso T, et al. Blood. 2020 Nov 12;136(20):2290-2295. doi: 10.1182/blood.2020008423. Blood. 2020. PMID: 32959052 Free PMC article.
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient.
Szwebel TA, Veyer D, Robillard N, Eshagh D, Canoui E, Bruneau T, Contejean A, Azoulay C, Serrano T, Hueso T, Izquierdo L, Rozenberg F, Terrier B, Vignon M, Laurent-Puig P, Taly V, Bélec L, Kernéis S, Lacombe K, Péré H. Szwebel TA, et al. Among authors: hueso t. Stem Cell Rev Rep. 2021 Feb;17(1):296-299. doi: 10.1007/s12015-020-10107-5. Epub 2021 Jan 5. Stem Cell Rev Rep. 2021. PMID: 33403488 Free PMC article.
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.
Duléry R, Lamure S, Delord M, Di Blasi R, Chauchet A, Hueso T, Rossi C, Drenou B, Deau Fischer B, Soussain C, Feugier P, Noël N, Choquet S, Bologna S, Joly B, Philippe L, Kohn M, Malak S, Fouquet G, Daguindau E, Taoufik Y, Lacombe K, Cartron G, Thiéblemont C, Besson C. Duléry R, et al. Among authors: hueso t. Am J Hematol. 2021 Aug 1;96(8):934-944. doi: 10.1002/ajh.26209. Epub 2021 May 12. Am J Hematol. 2021. PMID: 33909916 Free PMC article.
Severe COVID-19 in patients with hematological cancers presenting with viremia.
Michot JM, Hueso T, Ibrahimi N, Pommeret F, Willekens C, Colomba E, Francis S, Bayle A, Cournède PH, Merad M, Foulon S, Albiges L, Gachot B, Barlesi F, Soria JC, Ribrag V, Griscelli F. Michot JM, et al. Among authors: hueso t. Ann Oncol. 2021 Oct;32(10):1297-1300. doi: 10.1016/j.annonc.2021.07.002. Epub 2021 Jul 13. Ann Oncol. 2021. PMID: 34265373 Free PMC article. No abstract available.
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.
Pommeret F, Colomba J, Bigenwald C, Laparra A, Bockel S, Bayle A, Michot JM, Hueso T, Albiges L, Tiberghien P, Marot S, Jary A, Lacombe K, Barlesi F, Griscelli F, Colomba E. Pommeret F, et al. Among authors: hueso t. Ann Oncol. 2021 Nov;32(11):1445-1447. doi: 10.1016/j.annonc.2021.07.015. Epub 2021 Aug 2. Ann Oncol. 2021. PMID: 34352377 Free PMC article. No abstract available.
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis.
Hueso T, Godron AS, Lanoy E, Pacanowski J, Levi LI, Gras E, Surgers L, Guemriche A, Meynard JL, Pirenne F, Idri S, Tiberghien P, Morel P, Besson C, Duléry R, Lamure S, Hermine O, Gagneux-Brunon A, Freymond N, Grabar S, Lacombe K. Hueso T, et al. Leukemia. 2022 Apr;36(4):1025-1034. doi: 10.1038/s41375-022-01511-6. Epub 2022 Feb 1. Leukemia. 2022. PMID: 35105946 Free PMC article.
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort.
Albiges L, Foulon S, Bayle A, Gachot B, Pommeret F, Willekens C, Stoclin A, Merad M, Griscelli F, Lacroix L, Netzer F, Hueso T, Balleyguier C, Ammari S, Colomba E, Baciarello G, Perret A, Hollebecque A, Hadoux J, Michot JM, Chaput N, Saada V, Hauchecorne M, Micol JB, Sun R, Valteau-Couanet D, André F, Scotte F, Besse B, Soria JC, Barlesi F. Albiges L, et al. Among authors: hueso t. Nat Cancer. 2020 Oct;1(10):965-975. doi: 10.1038/s43018-020-00120-5. Epub 2020 Sep 22. Nat Cancer. 2020. PMID: 35121871
20 results